Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia

In coronavirus disease 2019 pneumonia, a cytokine storm resulting from an excessive inflammatory response to the viral infection is thought to play a role in the exacerbation of the pneumonia and its prognosis. Favipiravir and ciclesonide are not effective in the inhibition of the cytokine storm. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinomiya, Shohei, Nakase, Keisuke, Fujii, Ai, Takahara, Yutaka, Adachi, Hiroki, Okuro, Masashi, Iinuma, Yoshitsugu, Yokoyama, Hitoshi, Ito, Toru, Mizuno, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970680/
https://www.ncbi.nlm.nih.gov/pubmed/33796310
http://dx.doi.org/10.1177/2050313X21991063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970680/
https://www.ncbi.nlm.nih.gov/pubmed/33796310
http://dx.doi.org/10.1177/2050313X21991063

Ejemplares similares